ArticleScientific reports2026
An integrated multi-factor decision model for personalized NIPT timing using BMI stratification.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Non-invasive prenatal testing (NIPT) is a prenatal screening technique that analyzes cell-free fetal DNA in maternal blood plasma, widely used for early detection of fetal chromosomal abnormalities such as trisomy 21, 18, and 13. To optimize personalized testing timing and improve the detection accuracy of chromosomal abnormalities in female fetuses, this study developed a data-driven multifactorial modeling framework. The study population consisted of 1,687 pregnant women from a certain region. Correlation analysis and a nonlinear mixed-effects model (M4) were employed to quantify the relationships among gestational age, body mass index (BMI), and Y-chromosome concentration. The model results showed a positive correlation between gestational age and Y-chromosome concentration, while BMI and height were significantly negatively correlated with Y-chromosome concentration, providing statistical support for subsequent BMI-based stratification. Building on this, the study further predicted the earliest possible gestational week at which fetal DNA concentration reaches the detection threshold for each pregnant woman. A joint optimization model for BMI grouping and testing timing was constructed to determine the optimal testing time for each group, and the interaction between BMI and gestational age was validated using K-means clustering incorporating multiple factors. The model results indicated that the M4 model exhibited the best goodness of fit. As BMI increased, the recommended testing time was postponed from 13.8 weeks to 21.5 weeks. Additionally, to address the issues of limited data and the absence of Y-chromosome signals in female fetuses, this study systematically compared decision tree, random forest, and support vector machine (SVM) models, constructing a multi-feature fusion-based classification system. In the task of classifying chromosomal abnormalities in female fetuses, the SVM model performed the best, with X-chromosome concentration and GC content identified as key discriminatory features. The comprehensive multifactorial model proposed in this study can effectively predict personalized NIPT timing, help reduce the risk of testing failure, enhance the detection performance for chromosomal abnormalities in female fetuses, and thereby provide scientific basis and methodological support for the clinical application of NIPT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.